| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.5 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |